For sponsors and CROs
Emtrial structures inclusion and exclusion criteria from the study protocol. Research sites assess them against approved clinical data and release an aggregate response for the sponsor or CRO.
The response
Every response shows the available patient population, the criteria used, open assumptions, and the clinical data sources included in the assessment. The site approves the aggregate information before it is shared.
Patient availability
Emtrial gives sponsors an early, data-supported view of the target population. Staffing, infrastructure, budget, and investigator interest remain part of the standard site-feasibility process.
AI structures the protocol criteria and makes assumptions and ambiguity visible before a site starts the assessment.
The site team assesses the criteria against approved clinical data. Patient-level data and results remain under hospital control.
Sponsors receive structured cohort information, open questions, and the assessment scope in one consistent format.
One patient-population assessment
Each step has a clear owner. The sponsor defines the question, Emtrial structures it, and the research site controls the assessment and disclosure.
The sponsor or its CRO submits the eligibility criteria, assumptions, and the questions the site should answer.
AI turns the protocol into a consistent draft and flags ambiguity before the local assessment begins.
The site team reviews the criteria and assesses them against approved clinical data inside hospital-controlled systems.
The site decides which aggregate patient-population information and open questions may be shared with the sponsor or CRO.
Trust boundary
The local study team reviews potential matches. Sponsors and CROs receive only aggregate information approved by the research site.
Only aggregate information approved by the research site crosses this boundary.
Site-approved response
A structured response shows whether the target population is present, which criteria the available data supports, and where uncertainty remains. Patient-level records never become part of the sponsor view.
Recruitment pressure
Recruitment problems affect timelines, budgets, and planned study duration. These published figures describe the cited trials, not Emtrial performance.
Enrollment timelines
of trials miss enrollment timelines
Daily delay cost
estimated loss for each delayed trial day
Duration overrun
average overrun versus planned trial duration
Sources and method: Brøgger-Mikkelsen et al., PLOS ONE (2022) Brøgger-Mikkelsen et al., PLOS ONE (2022) Raftery et al., NIHR HTA (2015) · 125 publicly funded UK RCTs